Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 39 out of 100. Mild cognitive impairment

Reviewed as evidence on: Gut microbial metabolite (imidazole propionate, ImP) / microbiome and AD risk, pathology, decline rate 3 studies (what the news said). Being listed means the study bears on the question, not that it agrees with the news.

Topic: Risk, prevention and care in population studies

Mild Cognitive Impairment (MCI) is a transitional stage between normal age-related cognitive decline and the more severe cognitive loss seen in dementia. MCI presents a higher risk of progressing to Alzheimer’s and other neurodegenerative conditions despite its early symptoms overlapping with normal cognitive aging. Early identification is crucial for timely intervention, as no cure exists, and current treatments only slow disease progression. Eye tracking is a promising diagnostic solution, offering a non-invasive method to examine cognitive functions related to eye movements. In this article, we comprehensively reviewed how recent research studies have implemented eye-tracking technology to study cognitive disorders, focusing on MCI. We reviewed a broad spectrum of research studies employing eye-tracking methods and provided a cohesive overview of the different methodological approaches. We highlighted key advancements in detecting MCI using commonly analyzed eye movements and innovative eye-tracking techniques. Additionally, we analyzed recent studies that applied statistical, machine learning, and deep learning methods to eye-tracking data for MCI detection, followed by a detailed discussion on their challenges and limitations towards clinical applications. • Comprehensive review of eye-tracking in cognitive disorder research, focusing on MCI/AD. • Survey of gaze-based biomarkers and emerging paradigms in early disease detection. • Analysis of statistical, ML, and deep learning methods for diagnostic classification. • Discussion of clinical challenges in feasibility, generalizability, and deployment.

Key findings

Why it matters

This review describes eye tracking as a promising non-invasive method to examine cognitive functions related to eye movements for detecting mild cognitive impairment. It notes that no cure exists and current treatments only slow disease progression.

Study details

How this study scored 39/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 2 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomised / blinded 0 of 2; Times cited 2 of 7; Citations per year 2 of 5; Impact for its field and year 3 of 6; Cited by studies here 0 of 6; Still being cited 1 of 4; Senior author's track record 2 of 4; Institution's track record 1 of 3; Multi-centre collaboration 1 of 3; Indexed in PubMed 1 of 2; Free to read 2 of 2. Total 39 of 100.39 of 100 points earned61 not earned

Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomised / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Information Fusion)
Journal's citation record 2 / 4 Information Fusion: journal h-index 221 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 2 / 7 Cited 11 times (OpenAlex, 2026-10-10)
Citations per year 2 / 5 3.7 citations a year over 3 year(s) since 2025
Impact for its field and year 3 / 6 Cited 7.0× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 1 / 4 Cited 11 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 2 / 4 Last-listed author Roman Bednarik: h-index 30 (OpenAlex, whole career)
Institution's track record 1 / 3 University of Helsinki: institution h-index 1,201 (OpenAlex)
Multi-centre collaboration 1 / 3 OpenAlex lists 2 institution(s) in 1 country
Indexed in PubMed 1 / 2 Not in PubMed, but has a DOI
Free to read 2 / 2 Free to read
Total 39 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

APA 7th

Shah, H. A., Khalil, S., Andberg, S., Koivisto, A. M., & Bednarik, R. (2025). Eye tracking based detection of mild cognitive impairment: A review. Information Fusion. https://doi.org/10.1016/j.inffus.2025.103202

Vancouver

Shah HA, Khalil S, Andberg S, Koivisto AM, Bednarik R. Eye tracking based detection of mild cognitive impairment: A review. Information Fusion. 2025. doi:10.1016/j.inffus.2025.103202.

BibTeX

@article{shah2025-1b1a6cf1,
  author  = {Shah, Hasnain Ali and Khalil, Salman and Andberg, Sami and Koivisto, Anne Maria and Bednarik, Roman},
  title   = {{Eye tracking based detection of mild cognitive impairment: A review}},
  journal = {Information Fusion},
  year    = {2025},
  doi     = {10.1016/j.inffus.2025.103202},
  url     = {https://doi.org/10.1016/j.inffus.2025.103202}
}

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in Mild cognitive impairment

Also tagged “gut-microbial-metabolites-and-ad”

3 studies in the library carry the topic tag “gut-microbial-metabolites-and-ad”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 3 tagged studies.

Similar studies

More on Mild cognitive impairment

See all studies in Mild cognitive impairment →